Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Cancer

Explore clinical trials studying Head and Neck Squamous Cell Cancer. Study availability and eligibility vary by location and protocol.

15 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Cancer trial results

Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • START New York Long Island Lake Success, New York, United States
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

Study of XB010 in Subjects With Solid Tumors

NCT06545331

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +31 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NCT06682793

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Enrolling by Invitation

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

NCT07218003

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
Locations
  • UCSF Medical Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

NCT01351103

Conditions
BRAF Mutant Colorectal Cancer, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Onc Dept. Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details
Completed

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

NCT03667482

Conditions
Head and Neck Squamous Cell Cancer, Metastatic Head and Neck Squamous Cell Cancer, Recurrent Head and Neck Squamous Cell Cancer
Locations
  • Baptist Alliance MCI Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details

Related conditions